These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 26386881

  • 1. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT, Bloom R, Nouri K.
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [Abstract] [Full Text] [Related]

  • 2. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
    Goyal A, O'Leary D, Goyal K, Patel K, Pearson D, Janakiram M.
    J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
    [Abstract] [Full Text] [Related]

  • 4. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD.
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
    Criscione VD, Weinstock MA.
    Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
    Ai WZ, Keegan TH, Press DJ, Yang J, Pincus LB, Kim YH, Chang ET.
    JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
    Maurelli M, Tessari G, Colato C, Schena D, Girolomoni G.
    Eur J Dermatol; 2018 Feb 01; 28(1):44-49. PubMed ID: 29171395
    [Abstract] [Full Text] [Related]

  • 12. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
    Senerchia AA, Ribeiro KB, Rodriguez-Galindo C.
    Pediatr Blood Cancer; 2014 Feb 01; 61(2):211-6. PubMed ID: 24174376
    [Abstract] [Full Text] [Related]

  • 13. Increased malignancy risk in the cutaneous T-cell lymphoma patient population.
    Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic M.
    Clin Lymphoma Myeloma; 2008 Apr 01; 8(2):100-5. PubMed ID: 18501103
    [Abstract] [Full Text] [Related]

  • 14. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K, Makkar HS.
    Clin Dermatol; 2016 Apr 01; 34(6):749-759. PubMed ID: 27968935
    [Abstract] [Full Text] [Related]

  • 15. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma.
    Väkevä L, Pukkala E, Ranki A.
    J Invest Dermatol; 2000 Jul 01; 115(1):62-5. PubMed ID: 10886509
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Pehr K, Sasseville D, Litvinov IV.
    Cancer; 2017 Sep 15; 123(18):3550-3567. PubMed ID: 28493286
    [Abstract] [Full Text] [Related]

  • 17. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R, Bazzeh F, Faqih N, Sultan I.
    Cancer; 2010 Sep 15; 116(18):4385-94. PubMed ID: 20549819
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification.
    Nagasawa T, Miwa H, Nakatsuka S, Itami S, Yoshikawa K, Aozasa K.
    Am J Dermatopathol; 2000 Dec 15; 22(6):510-4. PubMed ID: 11190442
    [Abstract] [Full Text] [Related]

  • 19. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013.
    Eder J, Kern A, Moser J, Kitzwögerer M, Sedivy R, Trautinger F.
    J Eur Acad Dermatol Venereol; 2015 Aug 15; 29(8):1517-23. PubMed ID: 25600184
    [Abstract] [Full Text] [Related]

  • 20. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC, Meijer CJ, Van der Putte SC, Hollema H, Geerts ML, Bezemer PD, Willemze R.
    J Pathol; 1994 Jan 15; 172(1):53-60. PubMed ID: 7931828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.